Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Accounts Payables (2018 - 2026)

Health Catalyst filings provide 9 years of Accounts Payables readings, the most recent being $11.7 million for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 30.72% to $11.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.7 million, a 30.72% increase, with the full-year FY2025 number at $9.4 million, down 18.11% from a year prior.
  • Accounts Payables hit $11.7 million in Q1 2026 for Health Catalyst, up from $9.4 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $14.3 million in Q3 2024 to a low of $4.4 million in Q4 2022.
  • Median Accounts Payables over the past 5 years was $8.0 million (2023), compared with a mean of $8.2 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 125.67% in 2024 and later crashed 65.38% in 2025.
  • Health Catalyst's Accounts Payables stood at $4.4 million in 2022, then soared by 50.11% to $6.6 million in 2023, then soared by 72.16% to $11.4 million in 2024, then fell by 18.11% to $9.4 million in 2025, then grew by 24.9% to $11.7 million in 2026.
  • The last three reported values for Accounts Payables were $11.7 million (Q1 2026), $9.4 million (Q4 2025), and $4.9 million (Q3 2025) per Business Quant data.